Montelad-LC Tablet is a combination medicine containing levocetirizine 5mg and montelukast 10mg. It is indicated for the treatment of chronic spontaneous urticaria, allergic rhinitis, and asthma. Levocetirizine, an H1 receptor antagonist, provides rapid and sustained relief from symptoms such as pruritus, erythema, and angioedema. Montelukast, a leukotriene receptor antagonist, inhibits the production of cysteinyl leukotrienes, which are potent bronchoconstrictors, thereby providing relief from bronchospasm, wheezing, and cough. The combination of these two agents synergistically enhances the therapeutic efficacy, allowing for improved patient outcomes. The tablet is designed to be taken once daily, with a recommended starting dose of one tablet. Patients with chronic spontaneous urticaria may experience rapid symptom resolution, while those with allergic rhinitis and asthma may experience improved symptom control and reduced exacerbations. Montelad-LC Tablet is contraindicated in patients with known hypersensitivity to any component of the tablet. As with any medication, it is essential to follow the recommended dosage and administration instructions, and to monitor patients for potential adverse effects.